The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study
Authors
Keywords
Peripheral arterial disease, Diabetes mellitus, Arteriosclerosis, Population studies
Journal
Cardiovascular Diabetology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-27
DOI
10.1186/s12933-015-0257-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
- (2014) Yuji Ishibashi et al. Cardiovascular Diabetology
- Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
- (2013) Yuji Ishibashi et al. Cardiovascular Diabetology
- Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study
- (2013) Yoshifumi Fukushima et al. Cardiovascular Diabetology
- What Fans the Fire
- (2011) Amy S. Major et al. CIRCULATION
- Plasma S100A12 Level Is Associated with Cardiovascular Disease in Hemodialysis Patients
- (2011) Y. Shiotsu et al. Clinical Journal of the American Society of Nephrology
- Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study
- (2011) J. W. Nin et al. DIABETES CARE
- Triglycerides and Amputation Risk in Patients With Diabetes: Ten-year follow-up in the DISTANCE study
- (2011) B. C. Callaghan et al. DIABETES CARE
- Forest Plot Viewer
- (2011) Abee L. Boyles et al. EPIDEMIOLOGY
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Selection of confounding variables should not be based on observed associations with exposure
- (2011) Rolf H. H. Groenwold et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- AGE restriction in diabetes mellitus: a paradigm shift
- (2011) Helen Vlassara et al. Nature Reviews Endocrinology
- Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients
- (2010) A. Nakashima et al. Clinical Journal of the American Society of Nephrology
- The ongoing tyranny of statistical significance testing in biomedical research
- (2010) Andreas Stang et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden
- (2010) Lars Kärvestedt et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease
- (2009) Nitin Mahajan et al. ATHEROSCLEROSIS
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
- The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease
- (2008) Mariella Catalano et al. CLINICAL BIOCHEMISTRY
- Peripheral Sensory Neuropathy Associates With Micro- or Macroangiopathy: Results from a population-based study of type 2 diabetic patients in Sweden
- (2008) L. Karvestedt et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search